scholarly journals Conceptual design and optimization of self microemulsifying drug delivery systems for dapsone by using Box-Behnken design

2021 ◽  
Vol 25(2) (25(2)) ◽  
pp. 179-195
Author(s):  
Jayashri MAHORE-Aniket SHELAR-Sanjeevani DESHKAR
2021 ◽  
Vol 61 ◽  
pp. 102241
Author(s):  
Kantaporn Kheawfu ◽  
Surachai Pikulkaew ◽  
Thomas Rades ◽  
Anette Müllertz ◽  
Louise von Gersdorff Jørgensen ◽  
...  

2013 ◽  
Vol 40 (10) ◽  
pp. 1358-1370 ◽  
Author(s):  
Samridhi Verma ◽  
Sandeep Kumar Singh ◽  
Priya Ranjan Prasad Verma ◽  
Mohd Neyaz Ahsan

2012 ◽  
Vol 431 (1-2) ◽  
pp. 161-175 ◽  
Author(s):  
Ana Maria Sierra Villar ◽  
Beatriz Clares Naveros ◽  
Ana Cristina Calpena Campmany ◽  
Monserrat Aróztegui Trenchs ◽  
Coloma Barbé Rocabert ◽  
...  

2019 ◽  
Vol 26 (5) ◽  
pp. 1671-1679 ◽  
Author(s):  
K. Srinivasa Rao ◽  
Md. Hamza ◽  
P. Ashok Kumar ◽  
K. Girija Sravani

2021 ◽  
Vol 2021 ◽  
pp. 1-21
Author(s):  
Pengyu Gao ◽  
Dan Zou ◽  
Ansha Zhao ◽  
Ping Yang

Achievement of high targeting efficiency for a drug delivery system remains a challenge of tumor diagnoses and nonsurgery therapies. Although nanoparticle-based drug delivery systems have made great progress in extending circulation time, improving durability, and controlling drug release, the targeting efficiency remains low. And the development is limited to reducing side effects since overall survival rates are mostly unchanged. Therefore, great efforts have been made to explore cell-driven drug delivery systems in the tumor area. Cells, particularly those in the blood circulatory system, meet most of the demands that the nanoparticle-based delivery systems do not. These cells possess extended circulation times and innate chemomigration ability and can activate an immune response that exerts therapeutic effects. However, new challenges have emerged, such as payloads, cell function change, cargo leakage, and in situ release. Generally, employing cells from the blood circulatory system as cargo carriers has achieved great benefits and paved the way for tumor diagnosis and therapy. This review specifically covers (a) the properties of red blood cells, monocytes, macrophages, neutrophils, natural killer cells, T lymphocytes, and mesenchymal stem cells; (b) the loading strategies to balance cargo amounts and cell function balance; (c) the cascade strategies to improve cell-driven targeting delivery efficiency; and (d) the features and applications of cell membranes, artificial cells, and extracellular vesicles in cancer treatment.


Sign in / Sign up

Export Citation Format

Share Document